BG
CPXX

BlackRock Group’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

BlackRock Group’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-13,579
Closed -$409K – 3052
2016
Q2 		$409K Buy
+13,579
New +$276K ﹤0.01% 2338

BlackRock Group's CPXX Position: Q3 2016 in Review

BlackRock Group sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 13,579 shares — an estimated $409K sold.

BlackRock Group first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $409K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • BlackRock Group reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • BlackRock Group sold 13,579 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $409K.
  • BlackRock Group first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • BlackRock Group's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $409K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on BlackRock Group's 13F filing for Q3 2016, filed 8 Nov 2016.